Goldfine ID - Search Results

1

Archaeology of NIDDM. Excavation of the "thrifty" genotype.

Wendorf M, Goldfine ID. Wendorf M, et al. Among authors: goldfine id. Diabetes. 1991 Feb;40(2):161-5. doi: 10.2337/diab.40.2.161. Diabetes. 1991. PMID: 1991567

2

Production of inhibitor of insulin-receptor tyrosine kinase in fibroblasts from patient with insulin resistance and NIDDM.

Sbraccia P, Goodman PA, Maddux BA, Wong KY, Chen YD, Reaven GM, Goldfine ID. Sbraccia P, et al. Among authors: goldfine id. Diabetes. 1991 Feb;40(2):295-9. doi: 10.2337/diab.40.2.295. Diabetes. 1991. PMID: 1846830

3

Effect of metformin on carbohydrate and lipoprotein metabolism in NIDDM patients.

Wu MS, Johnston P, Sheu WH, Hollenbeck CB, Jeng CY, Goldfine ID, Chen YD, Reaven GM. Wu MS, et al. Among authors: goldfine id. Diabetes Care. 1990 Jan;13(1):1-8. doi: 10.2337/diacare.13.1.1. Diabetes Care. 1990. PMID: 2404714

4

Insulin resistance and insulin secretion are determinants of oral glucose tolerance in normal individuals.

Reaven GM, Brand RJ, Chen YD, Mathur AK, Goldfine I. Reaven GM, et al. Diabetes. 1993 Sep;42(9):1324-32. doi: 10.2337/diab.42.9.1324. Diabetes. 1993. PMID: 8349044

5

Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction?

Evans JL, Goldfine ID, Maddux BA, Grodsky GM. Evans JL, et al. Among authors: goldfine id. Diabetes. 2003 Jan;52(1):1-8. doi: 10.2337/diabetes.52.1.1. Diabetes. 2003. PMID: 12502486 Review.

6

A fully human, allosteric monoclonal antibody that activates the insulin receptor and improves glycemic control.

Bhaskar V, Goldfine ID, Bedinger DH, Lau A, Kuan HF, Gross LM, Handa M, Maddux BA, Watson SR, Zhu S, Narasimha AJ, Levy R, Webster L, Wijesuriya SD, Liu N, Wu X, Chemla-Vogel D, Tran C, Lee SR, Wong S, Wilcock D, White ML, Corbin JA. Bhaskar V, et al. Among authors: goldfine id. Diabetes. 2012 May;61(5):1263-71. doi: 10.2337/db11-1578. Epub 2012 Mar 8. Diabetes. 2012. PMID: 22403294 Free PMC article.

7

Mechanisms of insulin-induced insulin-receptor downregulation. Decrease of receptor biosynthesis and mRNA levels.

Okabayashi Y, Maddux BA, McDonald AR, Logsdon CD, Williams JA, Goldfine ID. Okabayashi Y, et al. Among authors: goldfine id. Diabetes. 1989 Feb;38(2):182-7. doi: 10.2337/diab.38.2.182. Diabetes. 1989. PMID: 2644141

8

Skeletal muscle content of membrane glycoprotein PC-1 in obesity. Relationship to muscle glucose transport.

Youngren JF, Maddux BA, Sasson S, Sbraccia P, Tapscott EB, Swanson MS, Dohm GL, Goldfine ID. Youngren JF, et al. Among authors: goldfine id. Diabetes. 1996 Oct;45(10):1324-8. doi: 10.2337/diab.45.10.1324. Diabetes. 1996. PMID: 8826966

9

A novel small molecule that directly sensitizes the insulin receptor in vitro and in vivo.

Manchem VP, Goldfine ID, Kohanski RA, Cristobal CP, Lum RT, Schow SR, Shi S, Spevak WR, Laborde E, Toavs DK, Villar HO, Wick MM, Kozlowski MR. Manchem VP, et al. Among authors: goldfine id. Diabetes. 2001 Apr;50(4):824-30. doi: 10.2337/diabetes.50.4.824. Diabetes. 2001. PMID: 11289048

10

Membrane glycoprotein PC-1 inhibition of insulin receptor function occurs via direct interaction with the receptor alpha-subunit.

Maddux BA, Goldfine ID. Maddux BA, et al. Among authors: goldfine id. Diabetes. 2000 Jan;49(1):13-9. doi: 10.2337/diabetes.49.1.13. Diabetes. 2000. PMID: 10615944

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

310 results

Search Page

Filters